Meet our 2019 speakers

Amina Albeyatti

Head of Business Development

MyClinic.com

Sascha Alilovic

Partner

SHS

Roy Amariglio

Vice President

Orbimed

Simon Amies

Partner

Covington & Burling

Madeleine Armstrong

News Editor

Vantage

Steve Atkinson

CEO

Atlantic Therapeutics

Sophie Baratte

CEO

Cellnovo

Assaf Barnea

CEO

Sanara Ventures

Markus Bauman

Partner

Goodwin

Paul Bateman

CEO

Novate Medical

Alexander Belcredi

CEO

PhagoMed

Alessio Beverina

Founder and Managing Partner

Panakès Partners

Hubert Birner

Managing Partner

TVM Capital Life Science

Michael Bloch

Counsel

Allen & Overy

John Bowis

Former MP, MEP and UK Health Minister

Thomas Burt

Partner, Crossover Fund

Sofinnova

Martha Carruthers

Head of Life Sciences

Medopad

Supa Chantschool

Senior Healthcare Editorial Analyst

GlobalData

Pierre Chauvineau

VP, Rhythm Management

Boston Scientific

Alain Chevallier

Partner, Life Sciences

Truffle Capital

Katherine Cohen

Venture Partner

Panacea Venture

David Colpman

Non Exec Director

HRA Pharma, Forendo Pharma

Clive Cookson

Science Editor

Financial Times

Mick Cooper

Healthcare & Life Sciences Analyst

Trinity Delta

Laia Crespo

Head of Europe

Sanofi Ventures

Ian Crosbie

CEO

Sequana Medical

Adrian Dawkes

Managing Director

Pharma Ventures

John Dawson

CEO

Oxford Biomedica

Don DeBethizy

Director

Argenx

Fiona de Hemptinne

Venture Partner

UCB Ventures

Olivier Delporte

CEO

Miracor Medical

Emmanuel de Watteville

General Partner and Co-Founder

BlueOcean Ventures

Victor Dillard

CEO

Desktop Genetics

Dimitri Dimitriou

CEO

Immupharma

Helen Disney

Founder

Unblocked

Matthew Dodds

Vice President, Strategic Planning

Livanova

Lord Drayson

CEO

Sensyne Health

Jørgen Dreyer

CEO

Saniona

Rémi Droller

Managing Partner

Kurma Partners

Alan Edwards

Chairman

ESP Technology, ASEP Healthcare and Credent Medical

Lucie Ellis

Managing Editor

In Vivo

Johnston Erwin

VP Corporate Business Development

Eli Lilly

Peter Finan

Partner

Epidarex Capital

Jason Foster

Managing Partner

Health Equity Consulting

Joan Fitzpatrick

CEO

Kite Medical

Andrew Fried

Life Sciences, Global Industry Leader

IBM

Martin Frost

CEO

CMR Surgical

Jochen Gann

Head of Global M&A and Corporate Finance

Boehringer Ingelheim

Theo Godfrey

Senior Associate

CMS

Christian Glennie

Director - Equity Research, Healthcare

Stifel

Jonathan Goldstein

Director, Corporate Research and Ventures

Boston Scientific

Shaun Grady

VP Global Business Development

AstraZeneca

Mattias Häggblom

Portfolio Manager - Global Healthcare

Swedbank Robur

Conor Hanley

CEO

FIRE1

Mark Hahnel

Associate Founder

Genomes.io

Deborah Harland

Partner

SR One

Frank Hensel

Principal

High-Tech Gründerfonds

Tony Hickson

CBO

CRUK

John Hodgson

Independent Consultant

Asaf Homossany

Managing Director - EMEA

Nasdaq

Thomas Holm Pedersen

CEO

NMD Pharma

Sarah Hanson

Partner, Co-Chair Life Sciences & Healthcare Sector

CMS Cameron McKenna Nabarro Olswang

Guenter Huhle

Head of Johnson & Johnson Innovation

JLABS EMEA

Jackie Hunter

Chief Executive

BenevolentBio

Anthony Joseph

CTO

Unite Genomics

Christoph Kausch

Founding Partner & CEO

MTIP

Sahil Kirpekar

Business Development, Licensing and Commercial Strategy

Otsuka Pharma

Charity Kufaas

Vice President, Strategy & Business Development EMEA

Medtronic

Yiannis Kiachopoulos

CEO

Causaly

Philip Jarvis

Executive Chairman

ESP Technology

Sree Kant

Head of Business Development

Life Biosciences

Sameer Kothari

CEO

Zilico

Lara Koole

Principal

Philips Health Technology Ventures

Dmitry Kuzmin

Managing Partner

4BIO Capital Partners

Marc Lambrechts

Senior Investment Manager

Capricorn Venture Partners

Kit Latham

CEO

drfocused

Stephan Lensky

CBO / COO

EpimAb Biotherapeutics

Oliver Litzka

Partner

Andera Partners

Hugh Lloyd-Jukes

CEO

Oxehealth

Carole Longson

Former Director of NICE and CSO

ABPI

Thomas Lonngren

Former Head of EMA and Senior Advisor

NDA Group

Phil L'Huillier

Head of Business Development, Europe, European Innovation Hub

MSD

Catherine Longworth

Reporter, Medtech Insight

Pharma intelligence

Tim Luker

Emerging Technology & Innovation, BD

Eli Lilly

Eric Mangiardi

CEO

Q3 Medical

Sean Marett

CBO & CCO

BioNTech

Manish Marotkar

Head of Business Development

Siemens Healthineers Digital Ecosystem

Giovanni Mariggi

Partner

Medicxi

Robyn Meurant

Executive Director, Regulatory Services, IVDs and Medical Devices

NSF Health Sciences

Robbie McLaren

Partner

Latham & Watkins

John Milad

CEO

QuantaDT

Søren Møller

Managing Partner

Novo Seeds

Angeli Möller

Head of IT Business Partnering Research

Bayer Business Services

Piers Morgan

CFO

Verona Pharma

Carina Namih

Partner

Episode 1

Savvas Neophytou

Partner & Head of Life Sciences

Deepbridge Capital

Alexis Normand

Head of Embleema Blockchain

Embleema

Daniel O’Mahony

Partner

Seroba Life Sciences

Geraldine O’Keeffe

Partner

LSP

Natalie Pankova

COO

Project Shivom

Alex Pasteur

Partner

F-Prime Capital Partners

Morag Peberdy

Of Counsel

Covington & Burling

James Peyer

Managing Partner

Apollo Ventures

Martin Pfister

Senior Investment Manager

HTGF

David Pinniger

Fund Manager - Biotechnology

Polar Capital

John Power

CEO & Managing Director

Aerogen Ltd

Pablo Prieto

CTO

Lifebit

Luis Eduardo Hinojosa Puerta

CBO

BioCubaFarma

Aditya Puri

Partner - Investments

Xeraya Capital

Conrad Rasmus

Co-Founder

Protembis

Cécile Real

CEO

EndoDiag

Josh Richardson

Managing Director

Longitude Capital

Dan Rose

CEO

Limflow

Christoph Ruedig

Partner

Albion Capital

Josep Sanfeliu

Managing Partner

Asabys Partners

Dominic Schmidt

Partner

Syncona Investment Management

Matthew Scholz

CEO

Oisin Biotechnologies

Pavithra Sundaresan

Senior Director, New Ventures and Transactions, Immunology

Johnson & Johnson Innovation

Graziano Seghezzi

Managing Partner

Sofinnova Partners

Johan Sellström

Co-Founder

CareChain

Melanie Senior

Analyst and Specialist Writer

Life Sciences

Raja Sharif

CEO

FarmaTrust

Nigel Sheail

Global Head of M&A and BD&L

Novartis

David Shields

Head, Centers for Therapeutic Innovation East

Pfizer Worldwide Research & Development

Julie Simmonds

Director Equity Research

Panmure Gordon

Harpreet Singh

CEO

Immatics US

Yochi Slonim

CEO

Anima Biotech

Andy Smith

Director / Analyst, Healthcare

Edison

Patrik Sobocki

Investment Manager

Industrifonden

Lena Söderstrom

Board Member

Genovis, Dicot AB and Bio-Works Technologies

Bobby Soni

Partner - Life Science Investments

IP Group

Nikolaj Sorenson

CEO

Orexo

Ivo Staijen

Portfolio Manager

HBM Partners

Sten Stovall

Senior Editor

Informa Business Intelligence

Johan Strömquist

CEO

NDA Group

Teemu Suna

CEO

Nightingale Health

Casey Swerner

Investor

DN Capital

Ashu Tandon

Chief Commercial Officer

Syngene

Tina Tan

Executive Editor

Firstword Medtech

Ben Thorpe

Head of Healthcare Investment Banking EMEA

Goldman Sachs

Kai W. Trompeter

President & CEO

INSIGHTRA MEDICAL

David Tuch

CEO

Lightpoint Medical

Lisa Urquhart

Editor

Vantage

Anton Ussi

Director Operations & Finance

EATRIS

Patrick Van Beneden

Partner

Gimv

Laurent Vandebrouck

CEO

Chronolife and Connected Health Development

Peter Van de Berg

Senior Innovation Consultant

Philips Innovation Services

Bart Van Hooland

Founding Partner

DROIA

Edward Van Wezel

Managing Partner

BioGeneration Ventures

Gary Waanders

Managing Director - UK Healthcare Research

Bryan, Garnier & Co.

Susana Waesch

VP Quality Management & Regulatory Affairs

Ypsomed AG

Elaine Warburton

CEO

QuantumDx

Franz Warner Haas

COO

CureVac

Chris Weatherall

Vice President, RA/QA/QC

Meridian Bioscience

Nathalie Ter Wengel

European Head Worldwide Business Development

Pfizer

Tina Woods

Chair

Future Health Collective

Boris Zaitra

Global Head of M&A

Roche